Drugs / FAZA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02394652 | May 2015 → Jan 2021 | adenocarcinoma, adenosquamous carcinoma, cervical cancer | University Health Network, Toronto | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FAZA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02394652 ↗ |
| Modality | Diagnostic / imaging agent | “FAZA is an investigational imaging agent for positron emission tomography scans indicated for hypoxia.” NCT02394652 ↗ |